Daymark Wealth Partners LLC Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Daymark Wealth Partners LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 95.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,601 shares of the healthcare conglomerate’s stock after selling 110,652 shares during the quarter. Daymark Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,934,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director John H. Noseworthy purchased 300 shares of the business’s stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock valued at $31,607,768 over the last 90 days. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Down 1.1%

Shares of NYSE:UNH opened at $302.19 on Thursday. The stock has a fifty day simple moving average of $342.22 and a two-hundred day simple moving average of $458.07. The stock has a market capitalization of $274.13 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.45 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.93%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is presently 37.02%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on UNH shares. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Barclays dropped their target price on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a report on Friday, June 20th. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $415.57.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.